I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 42 800 VND Market Closed
Market Cap: 6.6T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Imexpharm Corp
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Imexpharm Corp
Operating Expenses Peer Comparison

Comparables:
H
DHT
C
DCL
D
DMC
D
DHG
T
TRA

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
I
Imexpharm Corp
VN:IMP
Operating Expenses
-â‚«437.7B
CAGR 3-Years
-11%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
H
HaTay Pharmaceutical JSC
VN:DHT
Operating Expenses
-â‚«120.5B
CAGR 3-Years
1%
CAGR 5-Years
7%
CAGR 10-Years
-4%
C
Cuu Long Pharmaceutical JSC
VN:DCL
Operating Expenses
-â‚«139.2B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Operating Expenses
-â‚«198.2B
CAGR 3-Years
5%
CAGR 5-Years
13%
CAGR 10-Years
3%
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Operating Expenses
-â‚«1.4T
CAGR 3-Years
-8%
CAGR 5-Years
6%
CAGR 10-Years
-1%
T
Traphaco JSC
VN:TRA
Operating Expenses
-â‚«904.4B
CAGR 3-Years
16%
CAGR 5-Years
6%
CAGR 10-Years
-7%

See Also

What is Imexpharm Corp's Operating Expenses?
Operating Expenses
-437.7B VND

Based on the financial report for Jun 30, 2024, Imexpharm Corp's Operating Expenses amounts to -437.7B VND.

What is Imexpharm Corp's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-4%

Over the last year, the Operating Expenses growth was 11%. The average annual Operating Expenses growth rates for Imexpharm Corp have been -11% over the past three years , -7% over the past five years , and -4% over the past ten years .

Back to Top